Treatment regimens for laryngeal and hypopharyngeal squamous cell carcinoma: a "real life" multicenter study of 2307 patients.
Hypopharyngeal cancer
Laryngeal cancer
Radiotherapy
Surgery
Treatment
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
22 Oct 2024
22 Oct 2024
Historique:
received:
18
07
2024
accepted:
11
09
2024
medline:
23
10
2024
pubmed:
23
10
2024
entrez:
22
10
2024
Statut:
aheadofprint
Résumé
This retrospective multicenter study aimed to evaluate surgical versus conservative treatment in patients with hypopharyngeal and laryngeal cancer under real world conditions. This study included 2307 patients diagnosed with hypopharyngeal or laryngeal squamous cell carcinoma (SCC) in five German tertiary head and neck centers between 01/2004 and 12/2014. Overall, 783 patients with advanced SCC consecutively underwent laryng(opharyng)ectomy (L(P)E). Patient chart data regarding age, sex, tumor location, TNM status, grading, indication for L(P)E, treatment modalities, R status, postoperative complications, and hospitalization time were analyzed. Patients with lacking data and incomplete staging and those who refused treatment or did not comply with the recommended treatment were excluded from survival analysis. A slight but significant increase was observed in L(P)E, referring to an increasing rate of tumor recurrence. While T1/2N0M0 laryngeal and hypopharyngeal cancer patients showed comparable overall survival (OS) for surgical and conservative treatment, surgery showed significantly better OS in lymph node-positive individuals and locally advanced tumor stages. Tumor recurrence occurred in more than one-third of the cases. In particular, in early glottic cancer recurrence, L(P)E represents a curative and safe treatment option, whereas in supraglottic and hypopharyngeal cancer, L(P)E was associated with reduced survival rates. Notably, 36% of patients with supraglottic cancer and 59% of patients with hypopharyngeal cancer recurrence could only be treated with palliative care. Comparable survival rates were demonstrated for cT1/2N0M0 laryngeal and hypopharyngeal SCC compared with primary chemo-/radiotherapy and larynx-preserving surgery. Better OS was achieved after surgery in nodal-positive patients and in those with locally advanced disease. Tumor recurrence should be anticipated in up to 39% of cases. Glottic cancer recurrence can be successfully and safely treated with L(P)E, whereas OS is reduced in hypopharyngeal cancer and possibly in supraglottic cancer.
Identifiants
pubmed: 39438293
doi: 10.1007/s00405-024-08990-6
pii: 10.1007/s00405-024-08990-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Jones TM, De M, Foran B, Harrington K, Mortimore S (2016) Laryngeal cancer: United Kingdom National multidisciplinary guidelines. J Laryngol Otol 130(S2):S75–S82
doi: 10.1017/S0022215116000487
pubmed: 27841116
pmcid: 4873912
Department of Veterans Affairs Laryngeal Cancer Study Group, Wolf GT, Fisher SG, Hong WK, Hillman R, Spaulding M, Laramore GE, Endicott JW, McClatchey K, Henderson WG (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690
doi: 10.1056/NEJM199106133242402
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098
doi: 10.1056/NEJMoa031317
pubmed: 14645636
Ko HC, Harari PM, Chen S, Wieland AM, Yu M, Baschnagel AM, Kimple RJ, Witek ME (2017) Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottic larynx. JAMA Otolaryngol Head Neck Surg 143(11):1126–1133
doi: 10.1001/jamaoto.2017.1756
pubmed: 29049434
pmcid: 5710357
Sanabria A, Chaves ALF, Kowalski LP, Wolf GT, Saba NF, Forastiere AA, Beitler JJ, Nibu KI, Bradford CR, Suárez C, Rodrigo JP, Strojan P, Rinaldo A, de Bree R, Haigentz M Jr, Takes RP, Ferlito A (2017) Organ preservation with chemoradiation in advanced laryngeal cancer: the problem of generalizing results from randomized controlled trials. Auris Nasus Larynx 44(1):18–25
doi: 10.1016/j.anl.2016.06.005
pubmed: 27397024
Nocini R, Molteni G, Mattiuzzi C, Lippi G (2020) Updates on larynx cancer epidemiology. Chin J Cancer Res 32(1):18–25
doi: 10.21147/j.issn.1000-9604.2020.01.03
pubmed: 32194301
pmcid: 7072014
Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W (2014) Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery. Head Neck 36(5):652–659
doi: 10.1002/hed.23338
pubmed: 23596018
Krebs in Deutschland 2009/2010 9. Ausgabe. Robert Koch-Institut (Hrsg.) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg.)
Sikora AG, Toniolo P, DeLacure MD (2004) The changing demographics of head and neck squamous cell carcinoma in the United States. Laryngoscope 114(11):1915–1923
doi: 10.1097/01.mlg.0000147920.66486.bc
pubmed: 15510014
Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS (2013) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852
doi: 10.1200/JCO.2012.43.6097
pubmed: 23182993
Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, Pignon JP, MACH-CH Collaborative group (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100(1):33–40
doi: 10.1016/j.radonc.2011.05.036
pubmed: 21684027
Pignon JP, le Maître A, Maillard E, Bourhis J (2009) MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14
doi: 10.1016/j.radonc.2009.04.014
pubmed: 19446902
Janoray G, Pointreau Y, Garaud P, Chapet S, Alfonsi M, Sire C, Jadaud E, Calais G (2016) Long-term results of a multicenter randomized phase III trial of induction chemotherapy with cisplatin, 5-fluorouracil, +/− docetaxel for larynx preservation. J Natl Cancer Inst. https://doi.org/10.1093/jnci/djv368
doi: 10.1093/jnci/djv368
pubmed: 26681800
Dietz A et al (2016) Final results of the randomized phase II DeLOS-II trial: induction chemotherapy (IC) followed by radiotherapy (R) vs. cetuximab (E) plus IC and R for functional larynx preservation in resectable laryngeal and hypopharyngeal cancer (LHSCC). J Clin Oncol 34(15_Suppl):6025
doi: 10.1200/JCO.2016.34.15_suppl.6025
D’Ascanio L, Piazza F (2018) Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottic larynx. JAMA Otolaryngol Head Neck Surg 144(6):542–543
doi: 10.1001/jamaoto.2018.0077
pubmed: 29621368
Budach W, Bölke E, Kammers K, Gerber PA, Orth K, Gripp S, Matuschek C (2016) Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): a meta-analysis of randomized trials. Radiother Oncol 118(2):238–243
doi: 10.1016/j.radonc.2015.10.014
pubmed: 26589131
Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, Blot E, Rives M, Reyt E, Tourani JM, Geoffrois L, Peyrade F, Guichard F, Chevalier D, Babin E, Lang P, Janot F, Calais G, Garaud P, Bardet E (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31(7):853–859
doi: 10.1200/JCO.2012.42.3988
pubmed: 23341517
Bourhis J, Le Maître A, Baujat B, Audry H, Pignon JP (2007) Meta-analysis of chemotherapy in head, neck cancer collaborative group; meta-analysis of radiotherapy in carcinoma of head, neck collaborative group; meta-analysis of chemotherapy in nasopharynx carcinoma collaborative group. Individual patients’ data meta-analyses in head and neck cancer. Curr Opin Oncol 19(3):188–194
doi: 10.1097/CCO.0b013e3280f01010
pubmed: 17414635
Lefebvre JL, Ang KK (2009) Larynx preservation consensus panel. Larynx preservation clinical trial design: key issues and recommendations—a consensus panel summary. Head Neck 31(4):429–441
doi: 10.1002/hed.21081
pubmed: 19283793
Lefebvre JL (2006) Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 7(9):747–755
doi: 10.1016/S1470-2045(06)70860-9
pubmed: 16945770
Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589
doi: 10.1200/JCO.2007.14.8841
pubmed: 18559875
pmcid: 4911537
Graboyes EM, Zhan KY, Garrett-Mayer E, Lentsch EJ, Sharma AK, Day TA (2017) Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: analysis of the National cancer data Base. Cancer 123(12):2248–2257
doi: 10.1002/cncr.30586
pubmed: 28182267
Birchall M (2005) EaStER—early stage glottic cancer: endoscopic excision for radiotherapy: a feasibility study. National Research Register N0212194189
Warner L, Chudasama J, Kelly CG, Loughran S, McKenzie K, Wight R, Dey P (2014) Radiotherapy versus open surgery versus endolaryngeal surgery (with or without laser) for early laryngeal squamous cell cancer. Cochrane Database Syst Rev 2014(12):CD002027
pubmed: 25503538
pmcid: 6599864
Ogoltsova ES (1990) Comparative evaluation of the efficacy of radiotherapy, surgery and combined treatment of stage I–II laryngeal cancer (T1–2N0M0) on the basis of cooperative studies. Vestn Oto-Rino-Laringol 3:3–7
Yoo J, Lacchetti C, Hammond JA, Gilbert RW (2014) Head and Neck Cancer Disease Site Group. Role of endolaryngeal surgery (with or without laser) versus radiotherapy in the management of early (T1) glottic cancer: a systematic review. Head Neck 36(12):1807–1819
doi: 10.1002/hed.23504
pubmed: 24115131
Higgins KM, Shah MD, Ogaick MJ, Enepekides D (2009) Treatment of early-stage glottic cancer: meta-analysis comparison of laser excision versus radiotherapy. J Otolaryngol Head Neck Surg 38(6):603–612
pubmed: 19958721
Abdurehim Y, Hua Z, Yasin Y, Xukurhan A, Imam I, Yuqin F (2012) Transoral laser surgery versus radiotherapy: systematic review and meta-analysis for treatment options of T1a glottic cancer. Head Neck 34(1):23–33
doi: 10.1002/hed.21686
pubmed: 21374753
Feng Y, Wang B, Wen S (2011) Laser surgery versus radiotherapy for T1–T2N0 glottic cancer: a meta-analysis. ORL J Oto-Rhino-Laryngol Relat Spec 73(6):336–342
doi: 10.1159/000327097
Wei WI (2002) The dilemma of treating hypopharyngeal carcinoma: more or less: Hayes Martin Lecture. Arch Otolaryngol Head Neck Surg 128(3):229–232
doi: 10.1001/archotol.128.3.229
pubmed: 11886334
Mimica X, Hanson M, Patel SG, McGill M, McBride S, Lee N, Dunn LA, Cracchiolo JR, Shah JP, Wong RJ, Ganly I, Cohen MA (2019) Salvage surgery for recurrent larynx cancer. Head Neck 41(11):3906–3915
doi: 10.1002/hed.25925
pubmed: 31433540
pmcid: 7485603
Tupper C (1965) Radical Wertheim as a salvage procedure. Patients with recurrence following initial definitive radiotherapy. Am J Obstet Gynecol 91:364–368
doi: 10.1016/0002-9378(65)90251-6
pubmed: 14258263
Sanabria A, Kowalski LP, Shaha AR, Silver CE, Werner JA, Mandapathil M, Takes RP, Strojan P, Rinaldo A, Ferlito A (2014) Salvage surgery for head and neck cancer: a plea for better definitions. Eur Arch Otorhinolaryngol 271(6):1347–1350
doi: 10.1007/s00405-014-2924-7
pubmed: 24532050